Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28700417 | 0.75 | MAPT (0.35) | MAPTCYP19A1ALDH1A1EGLN3FAAH | |
| SCHEMBL6236798 | 0.75 | MAPT (0.33) | MAPTCYP19A1KMT2A | |
| SCHEMBL15846673 | 0.72 | FAAH (0.45) | MAPTCYP19A1ALDH1A1EGLN3FAAH | |
| SCHEMBL618874 | 0.72 | ALDH1A1 (0.43) | MAPTCYP19A1ALDH1A1EGLN3FAAH | |
| SCHEMBL1325 | 0.72 | FAAH (0.45) | MAPTCYP19A1ALDH1A1EGLN3FAAH | |
| Tetranitromethane SCHEMBL4783630 | 0.72 | ALDH1A1 (0.34) | MAPTCYP19A1ALDH1A1HTT | |
| SCHEMBL6558961 | 0.70 | — | — | |
| SCHEMBL2194853 | 0.70 | FAAH (0.44) | MAPTCYP19A1ALDH1A1EGLN3FAAH | |
| Hydrogen Sulfide SCHEMBL10814521 | 0.70 | FAAH (0.44) | MAPTCYP19A1ALDH1A1EGLN3FAAH | |
| SCHEMBL173415 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111757758-A | Ultrasonic contrast agent based on bilirubin derivative for diagnosis and treatment | 株式会社毕丽斯 | 2020-10-09 | — | — | CN | disclosed |